Riskpilot← Back to searchSign inGet full accessSmallegade Fodterapi ApS
APSActiveCVR 13692378Smallegade 54Other human health activities n.e.c. · NACE 8699Est. 19891 employeeswww.smallegadefodterapi.dk
Revenue 2024
DKK 736K
-1% vs 2023
EBITDA margin
35.8%
-8% vs 2023
Equity ratio
19.6%
Financial strength
Net profit 2024
DKK 81K
+10% vs 2023
| Revenue | DKK 736K | -1% |
| EBITDA | DKK 264K | -8% |
| Net profit | DKK 81K | +10% |
| Total assets | DKK 1,6M | +1% |
| Equity | DKK 320K | +34% |
| Employees | 1 | — |
Legal name
Smallegade Fodterapi ApS
CVR number
13692378
Legal form
Anpartsselskab
NACE code
8699 · Other human health activities n.e.c.
Founded
1. december 1989
Share capital
DKK 125.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål som statsautoriseret fodterapeut er at drive fodterapivirksomhed og dermed beslægtet virksomhed.
Address
Smallegade 54
Phone
+4560801470
Email
kontakt@smallegadefodterapi.dk
Website
www.smallegadefodterapi.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 140 | 441 | 748 | 743 | 736 |
| Staff expenses | -0 | -393 | -527 | -456 | -473 |
| EBITDA | 140 | 48 | 221 | 287 | 264 |
| Depreciation & amort. | -60 | -72 | -92 | -96 | -69 |
| EBIT | 80 | -24 | 129 | 191 | 195 |
| Net financials | -44 | -67 | -61 | -80 | -95 |
| Profit before tax | 36 | -91 | 68 | 111 | 100 |
| Tax | -36 | -17 | 25 | 37 | 18 |
| Net profit | 72 | -74 | 43 | 74 | 81 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1.589 | 1.570 | 1.673 | 1.618 | 1.631 |
| Equity | 197 | 123 | 166 | 240 | 320 |
| Long-term debt | 0 | 1.062 | 1.025 | 1.008 | 1.001 |
| Short-term debt | 1.392 | 384 | 483 | 371 | 310 |
| Total debt | 1.392 | 1.447 | 1.507 | 1.378 | 1.311 |
EBITDA margin
35.8%
This company
15.8%
Market median
+127% vs market
20202024
Equity ratio
19.6%
This company
38.2%
Market median
-49% vs market
20202024
Return on equity
25.4%
This company
18.4%
Market median
+38% vs market
20202024
Net profit margin
11.0%
This company
8.1%
Market median
+36% vs market
20202024
Asset turnover
0.45×
This company
1.12×
Market median
-60% vs market
20202024
Debt / equity
4.09×
This company
0.62×
Market median
-560% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (8) | ||
LR Management | Management | 1989 – 1998 |
ET | Audit | 1989 – 1990 |
HV Management | Management | 2016 – 2020 |
JM Management | Management | 1989 – 1998 |
EM Management | Management | 1998 – 2003 |
CK Management | Management | 1996 – 2003 |
LN Management | Management | 1996 – 2016 |
PE Management | Management | 1989 – 1990 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2021 | |
| Board of Directors | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2020 | |
| Individual | 33.33–49.99% | 33.33–49.99% | 1996 | |
| Individual | 33.33–49.99% | 33.33–49.99% | 2016 | |
| Company | 50–66.65% | 50–66.65% | 2016 | |
| Individual | 33.33–49.99% | 33.33–49.99% | 2003 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MF1 ApS
Smallegade Fodterapi ApS Board members of Smallegade Fodterapi ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lillian Randi Katz | Management | 0 companies |
| Erik Tronborg Andersen | Audit | 0 companies |
| Henrik Vestergaard Sørensen | Management | 0 companies |
| Jytte Metha Beck | Management | 0 companies |
| Erica Munthe-Kaas | Management | 0 companies |
| Catharina Katz | Management | 0 companies |
| Lis Neel Reumert | Management | 0 companies |
| Per Emil Hasselbalch Stakemann | Management | 0 companies |
| Ditte Sofia Stends Damgaard | Chairman | 0 companies |
| Jørgen Christian Gad | Board of Directors | 0 companies |